Published in J Biol Chem on June 05, 1993
Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor. J Virol (2004) 2.47
Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations. Protein Sci (2002) 2.17
Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. J Virol (1995) 1.78
Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease. J Virol (2004) 1.65
Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease. Protein Sci (2002) 1.49
Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo. Proc Natl Acad Sci U S A (1998) 1.21
Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease. J Virol (2002) 1.17
Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy. Protein Sci (1996) 1.16
Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations. J Virol (2007) 1.13
Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity. J Virol (2006) 1.10
Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease. J Virol (2007) 1.06
Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem J (1996) 1.02
Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease. Protein Sci (1993) 0.99
The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways. J Virol (2010) 0.99
Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease. ACS Chem Biol (2012) 0.96
Molecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases. J Virol (1997) 0.94
Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease. Protein Sci (2009) 0.93
X-ray crystal structures of human immunodeficiency virus type 1 protease mutants complexed with atazanavir. J Virol (2007) 0.92
Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus. J Virol (1997) 0.90
Genetic selection for dissociative inhibitors of designated protein-protein interactions. Nat Biotechnol (2000) 0.89
The folding free-energy surface of HIV-1 protease: insights into the thermodynamic basis for resistance to inhibitors. J Mol Biol (2009) 0.88
Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain. J Virol (2000) 0.88
Flexible catalytic site conformations implicated in modulation of HIV-1 protease autoprocessing reactions. Retrovirology (2011) 0.85
Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach. Biochem J (2009) 0.85
An Escherichia coli expression assay and screen for human immunodeficiency virus protease variants with decreased susceptibility to indinavir. Antimicrob Agents Chemother (1998) 0.84
Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells. AIDS Res Ther (2010) 0.83
Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease. ACS Chem Biol (2012) 0.82
Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease. Proc Natl Acad Sci U S A (2014) 0.82
HIV-1 protease-substrate coevolution in nelfinavir resistance. J Virol (2014) 0.80
Structural and thermodynamic basis of amprenavir/darunavir and atazanavir resistance in HIV-1 protease with mutations at residue 50. J Virol (2013) 0.80
Understanding HIV-1 protease autoprocessing for novel therapeutic development. Future Med Chem (2013) 0.79
Total chemical synthesis of human T-cell leukemia virus type 1 protease via native chemical ligation. Biopolymers (2010) 0.79
A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity. PLoS One (2015) 0.79
Ionization state of the catalytic dyad Asp25/25' in the HIV-1 protease: NMR studies of site-specifically 13C labelled HIV-1 protease prepared by total chemical synthesis. Org Biomol Chem (2012) 0.78
Modulation of HIV protease flexibility by the T80N mutation. Proteins (2015) 0.77
A modular system to evaluate the efficacy of protease inhibitors against HIV-2. PLoS One (2014) 0.76
Trp42 rotamers report reduced flexibility when the inhibitor acetyl-pepstatin is bound to HIV-1 protease. Protein Sci (2000) 0.76
Characterization of the protease domain of Rice tungro bacilliform virus responsible for the processing of the capsid protein from the polyprotein. Virol J (2005) 0.75
C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain. J Virol (2017) 0.75
Structural basis of substrate specificity in the serine proteases. Protein Sci (1995) 4.22
Redesigning trypsin: alteration of substrate specificity. Science (1985) 3.70
Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc Natl Acad Sci U S A (2000) 3.06
Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci U S A (1987) 2.99
Splice junctions: association with variation in protein structure. Science (1983) 2.54
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem (2000) 2.50
Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nat Biotechnol (2000) 2.49
Structure of two related rat pancreatic trypsin genes. J Biol Chem (1984) 2.24
Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J Biol Chem (1997) 2.05
Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci U S A (1999) 2.01
The catalytic role of the active site aspartic acid in serine proteases. Science (1987) 1.88
The three-dimensional structure of Asn102 mutant of trypsin: role of Asp102 in serine protease catalysis. Science (1987) 1.87
Regulation of clathrin assembly and trimerization defined using recombinant triskelion hubs. Cell (1995) 1.80
Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. J Virol (1995) 1.78
Molecular cloning and primary structure of human 15-lipoxygenase. Biochem Biophys Res Commun (1988) 1.76
Domain flexibility in retroviral proteases: structural implications for drug resistant mutations. Biochemistry (1998) 1.75
Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem (1998) 1.65
Intron-exon splice junctions map at protein surfaces. Nature (1982) 1.65
Characterization of globin domains: heme binding to the central exon product. Proc Natl Acad Sci U S A (1980) 1.63
Isolation and sequence of a rat chymotrypsin B gene. J Biol Chem (1984) 1.61
The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi. J Biol Chem (1992) 1.58
Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci U S A (1990) 1.55
A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol (2001) 1.51
The exocrine protein trypsinogen is targeted into the secretory granules of an endocrine cell line: studies by gene transfer. J Cell Biol (1985) 1.50
Introduction of a cysteine protease active site into trypsin. Biochemistry (1989) 1.50
The crystal structure of cruzain: a therapeutic target for Chagas' disease. J Mol Biol (1995) 1.49
Selective alteration of substrate specificity by replacement of aspartic acid-189 with lysine in the binding pocket of trypsin. Biochemistry (1987) 1.48
Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Proc Natl Acad Sci U S A (1990) 1.46
A primary determinant for lipoxygenase positional specificity. Nature (1991) 1.45
Structure of the two related elastase genes expressed in the rat pancreas. J Biol Chem (1984) 1.43
Two approaches to discovering and developing new drugs for Chagas disease. Mem Inst Oswaldo Cruz (2009) 1.41
Immunologic and proteolytic analysis of HIV-1 reverse transcriptase structure. Virology (1990) 1.38
Substrate specificity of trypsin investigated by using a genetic selection. Proc Natl Acad Sci U S A (1990) 1.29
Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2. J Biol Chem (1990) 1.29
Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi. J Biol Chem (1993) 1.26
Site-directed mutagenesis shows that tyrosine 248 of carboxypeptidase A does not play a crucial role in catalysis. Nature (1985) 1.25
Viral proteases: evolution of diverse structural motifs to optimize function. Cell (1997) 1.24
Structural determinants of specificity in the cysteine protease cruzain. Protein Sci (1997) 1.24
Amplification and sequencing of genomic DNA fragments encoding cysteine proteases from protozoan parasites. Mol Biochem Parasitol (1990) 1.23
Perturbing the polar environment of Asp102 in trypsin: consequences of replacing conserved Ser214. Biochemistry (1992) 1.22
Isolation and characterization of a cDNA encoding rat cationic trypsinogen. Biochemistry (1987) 1.22
Expression of cloned human reticulocyte 15-lipoxygenase and immunological evidence that 15-lipoxygenases of different cell types are related. J Biol Chem (1990) 1.21
A novel rat carboxypeptidase, CPA2: characterization, molecular cloning, and evolutionary implications on substrate specificity in the carboxypeptidase gene family. J Biol Chem (1988) 1.17
Synthetic "interface" peptides alter dimeric assembly of the HIV 1 and 2 proteases. Protein Sci (1992) 1.17
The sequence and reactive site of ecotin. A general inhibitor of pancreatic serine proteases from Escherichia coli. J Biol Chem (1991) 1.15
Inhibition of HIV protease activity by heterodimer formation. Biochemistry (1991) 1.15
Molecular cloning of dog mast cell tryptase and a related protease: structural evidence of a unique mode of serine protease activation. Biochemistry (1989) 1.13
Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements. Biochemistry (2000) 1.12
Structure-based design of parasitic protease inhibitors. Bioorg Med Chem (1996) 1.12
Serine proteases from nematode and protozoan parasites: isolation of sequence homologs using generic molecular probes. Proc Natl Acad Sci U S A (1989) 1.11
Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation. Proc Natl Acad Sci U S A (1995) 1.10
Relocating a negative charge in the binding pocket of trypsin. J Mol Biol (1993) 1.08
Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem (1993) 1.08
The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Virol (1997) 1.04
Structural characterization of the rat carboxypeptidase A1 and B genes. Comparative analysis of the rat carboxypeptidase gene family. J Biol Chem (1988) 1.03
Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem J (1996) 1.02
In vitro mutagenesis of trypsinogen: role of the amino terminus in intracellular protein targeting to secretory granules. J Cell Biol (1987) 1.02
Evolution of catalysis in the serine proteases. Cold Spring Harb Symp Quant Biol (1987) 1.02
Engineered metalloregulation in enzymes. Trends Biochem Sci (1992) 1.01
The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity. Nat Struct Biol (2000) 1.01
Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI. J Mol Biol (1993) 1.01
Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro. J Biol Chem (1990) 1.01
Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus. Biochemistry (2007) 1.01
Structure of an engineered, metal-actuated switch in trypsin. Biochemistry (1993) 0.99
Three-dimensional structures of HIV-1 and SIV protease product complexes. Biochemistry (1996) 0.99
Regulation of serine protease activity by an engineered metal switch. Biochemistry (1990) 0.98
Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design. J Biol Chem (1993) 0.98
Efficient targeting to storage granules of human proinsulins with altered propeptide domain. J Cell Biol (1988) 0.97
Auto-inactivation by cleavage within the dimer interface of Kaposi's sarcoma-associated herpesvirus protease. J Mol Biol (1999) 0.97
O2 binding properties of the product of the central exon of beta-globin gene. Nature (1981) 0.97
Development of an efficient method for generating and screening active trypsin and trypsin variants. Ann N Y Acad Sci (1988) 0.97
Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation. Proc Natl Acad Sci U S A (1996) 0.97
Crystal structure of an ecotin-collagenase complex suggests a model for recognition and cleavage of the collagen triple helix. Biochemistry (1997) 0.96
Constitutive production of nonenveloped human immunodeficiency virus type 1 particles by a mammalian cell line and effects of a protease inhibitor on particle maturation. Antimicrob Agents Chemother (1994) 0.96
X-ray structures of a designed binding site in trypsin show metal-dependent geometry. Biochemistry (1996) 0.94
Structural and functional integrity of specificity and catalytic sites of trypsin. Int J Pept Protein Res (1988) 0.93
Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage display of ecotin. J Biol Chem (1995) 0.93
Isolation and characterization of cDNAs from Atlantic cod encoding two different forms of trypsinogen. Eur J Biochem (1993) 0.92
Locating the catalytic water molecule in serine proteases. Science (1993) 0.91
Single amino acids changes in the signal receptor domain of XylR resulted in mutants that stimulate transcription in the absence of effectors. J Biol Chem (1995) 0.91
Can small cyclic peptides have the activity and specificity of proteolytic enzymes? Proc Natl Acad Sci U S A (1994) 0.91
Definition of the extended substrate specificity determinants for beta-tryptases I and II. J Biol Chem (2001) 0.91
Ecotin: a serine protease inhibitor with two distinct and interacting binding sites. J Mol Biol (1998) 0.90
1.59 A structure of trypsin at 120 K: comparison of low temperature and room temperature structures. Proteins (1991) 0.90
Arachidonate 15-lipoxygenase (omega-6 lipoxygenase) from human leukocytes. Purification and structural homology to other mammalian lipoxygenases. J Biol Chem (1988) 0.89
The substrate specificity of Uca pugilator collagenolytic serine protease 1 correlates with the bovine type I collagen cleavage sites. J Biol Chem (1994) 0.89
Use of the intestinal bile acid transporter for the uptake of cholic acid conjugates with HIV-1 protease inhibitory activity. Pharm Res (1997) 0.89
Specific inhibition of HIV-1 protease by boronated porphyrins. J Med Chem (1992) 0.88
Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases. J Mol Biol (2000) 0.88
The role of ecotin dimerization in protease inhibition. J Mol Biol (2001) 0.88
Determining protein-protein interactions by oxidative cross-linking of a glycine-glycine-histidine fusion protein. Biochemistry (1998) 0.88
Structural basis for the broad substrate specificity of fiddler crab collagenolytic serine protease 1. Biochemistry (1997) 0.87
The glucose-lowering agent sodium tungstate increases the levels and translocation of GLUT4 in L6 myotubes through a mechanism associated with ERK1/2 and MEF2D. Diabetologia (2008) 0.87
Engineering enzyme specificity. Curr Opin Chem Biol (1998) 0.86
Crystal structures of two engineered thiol trypsins. Biochemistry (1989) 0.86
Calcium-free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2. Proteins (1991) 0.86
Arachidonate 15-lipoxygenase from human eosinophil-enriched leukocytes: partial purification and properties. Biochem Biophys Res Commun (1988) 0.86
An expression system for trypsin. J Cell Biochem (1989) 0.85